Related Experiment Videos
Carotid endarterectomy
1DHHS, PHS, Agency for Health Care Policy and Research (AHCPR), Rockville, MD 20857.
Insights
Carotid endarterectomy, a surgery for carotid artery disease, has uncertain benefits for stroke prevention. Ongoing trials are needed to determine its effectiveness compared to nonoperative management for patients with transient ischemic attacks or asymptomatic stenosis.
Area of Science:
- Vascular Surgery
- Neurology
- Clinical Trials
Background:
- Carotid endarterectomy removes atherosclerotic blockages from the carotid artery.
- It's performed to reduce stroke risk and improve cerebral blood flow in patients with transient ischemic attacks (TIAs), asymptomatic stenosis, or stroke.
- Existing studies on its efficacy have yielded conflicting or inconclusive results, with wide variations in complication rates.
Purpose of the Study:
- To evaluate the established benefits of carotid endarterectomy for patients with carotid artery disease.
- To compare surgical intervention with nonoperative management strategies.
- To identify patient subsets who may benefit most from this procedure.
Main Methods:
- Review of existing literature and clinical trial data.
- Analysis of morbidity and mortality rates associated with the procedure.
- Assessment of studies comparing carotid endarterectomy to nonoperative management.
Main Results:
- No prospective clinical trial has definitively proven carotid endarterectomy superior or inferior to nonoperative management for any patient group.
- Evidence supporting benefits for patients with TIAs is inconclusive.
- The advantages for asymptomatic patients with carotid artery disease are even less clear.
Conclusions:
- The benefits of carotid endarterectomy remain indeterminate pending results from ongoing prospective, randomized, controlled clinical trials.
- Current alternative treatments have not demonstrated superior therapeutic outcomes.
- Further research is required to establish optimal therapy and identify patient subgroups likely to benefit.
Abstract:
Carotid endarterectomy is a surgical procedure to remove atherosclerotic occlusions from the carotid artery. The surgery is usually performed in patients with transient ischemic attacks (TIAs), asymptomatic stenosis, or stroke in order to reduce stroke risk and increase cerebral blood flow. Complication rates vary widely among surgeons and hospitals, and numerous studies testing the efficacy of carotid endarterectomy and documenting its associated morbidity and mortality have produced conflicting or inconclusive results. No properly designed prospective clinical trial has convincingly demonstrated this surgery to be superior or inferior to nonoperative management for any subset of patients with carotid artery disease. There has been no definitive study concluding that patients with TIA benefit from carotid endarterectomy. The benefits for asymptomatic patients are even less clear. Among the alternative surgical and medical treatments advocated for occlusive carotid disease, none has clearly demonstrated superior therapeutic results. It is generally agreed that current ongoing prospective, randomized, controlled clinical trials are likely to provide the data required for determination of optimal therapy and better identify subsets of patients who are most likely to benefit from carotid endarterectomy. Until the results of these clinical trials become available, the proposed benefits of carotid endarterectomy must be regarded as indeterminate.